Dr. Bob S. Carter is CEO of University of Utah Health and the A. Lorris Betz Senior Vice President for Health Sciences at the University of Utah, joins a community of 34,000 dedicated faculty, staff, and students who work in partnership to advance U of U Health's clinical, research, education, and community service missions. Together, the U of U Health community aspires to build on the health system's remarkable legacy and envision bold new opportunities for the future.

Prior to this role, Dr. Carter was privileged to lead one of the nation's most innovative neuroscience communities as Neurosurgeon-in-Chief at Mass General Brigham and the William and Elizabeth Sweet Professor of Neuroscience at Harvard Medical School. He has also served as Co-Founder and Co-Chair of Mass General Neuroscience, Chief of Neurosurgery and Department Chair at the University of California, San Diego, and Chair of Neurosurgery at Massachusetts General Hospital. Dr. Carter is widely recognized for his contributions to brain tumor genetics, gene and cell therapy for neurological disorders, and the development of liquid biopsy techniques for glioblastoma. He has published over 220 original research articles and holds multiple patents for his innovative work.

Dr. Carter specializes in the surgical management of complex intracranial and skull base tumors, including meningiomas, pituitary and craniopharyngioma tumors, vestibular schwannomas, and challenging gliomas. Patients from around the globe seek his team's expertise in brain tumor care.

Throughout his career, Dr. Carter has demonstrated a steadfast commitment to leadership in academic medicine, fostering collaborative initiatives, enhancing clinical excellence, and advancing neurosurgical education and research. In recognition of his efforts to advance these missions, he has been named the Honored Guest of the Congress of Neurological Surgeons, a Distinguished Alumnus of the Johns Hopkins School of Medicine, and is an elected Member of the National Academy of Medicine.

Dr. Carter is a graduate of the Johns Hopkins University Schools of Medicine (M.D.) and Public Health (Ph.D. Epidemiology) and the Brigham Young University (B.A. Chemistry).